✨ Free AI Report
Tristel plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Company Research

Tristel plc: Business Overview, Financials & Competitive Analysis

Tristel plc scores 8/10 on the AskCyborg Cyborg Score (Strong). Debt-free, profitable healthcare company with proprietary technology, consistent double-digit growth targets, and expanding product portfolio in high-margin infection prevention market. The company reported strong financial results, achieved FDA clearance of Tristel OPH, and published independent clinical evidence with leading institutions like Mayo Clinic. Strong cash generation and continued disciplined execution.

What is Tristel plc's industry? Tristel plc (tristel.com) operates in Healthcare - Infection Control/Hospital Disinfection Products. AskCyborg classifies Tristel plc under Healthcare - Infection Control/Hospital Disinfection Products in its company registry.

Tristel plc is a manufacturer of infection prevention products for hospitals, specializing in chlorine dioxide chemistry used for the decontamination of medical devices and sporicidal disinfection of environmental sur...

8/ 10Strong

Cyborg Score thesis

Debt-free, profitable healthcare company with proprietary technology, consistent double-digit growth targets, and expanding...

Read the full analyst-debate transcript →
Industry Healthcare - Infection Control/Hospital Disinfection Products
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Tristel plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Tristel plc

AskCyborg analysts argue the bull and bear cases for Tristel plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Tristel plc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Tristel plc Overview

Pro stress-test →

Tristel plc is a manufacturer of infection prevention products for hospitals, specializing in chlorine dioxide chemistry used for the decontamination of medical devices and sporicidal disinfection of environmental surfaces. The company serves a critical healthcare market segment with proprietary technology and operates globally across 40+ countries.

Strategic Profile

Pro stress-test →

Tristel's strategy is to sustain double-digit growth and deliver long-term value by extending leadership in point-of-care medical device disinfection and sporicidal surface disinfection. Operating from Snailwell near Cambridge with approximately 270 employees across 16 subsidiaries, the company maintains a debt-free balance sheet and targets EBITDA margins of at least 25%.

Competitive Landscape

Pro stress-test →

Tristel's core competitive advantage lies in proprietary chlorine dioxide chemistry domain knowledge with R&D focused on microbial efficacy improvements and manufacturing efficiency. The company operates in the hospital infection control market where regulatory barriers and clinical validation create switching costs. Primary competitors include larger medical device manufacturers and regional disinfection product providers.

Industry Context

Tristel plc operates in Healthcare - Infection Control/Hospital Disinfection Products.

Key facts

Founded: 1993 · Headquarters: Snailwell, United Kingdom · Employees: 270 · Revenue: $55.7M · Market cap: $207M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Tristel plc.

  • FDA clearance of Tristel OPH and recognition of chlorine dioxide foam in updated US standards expand addressable market
  • New product launches including VISICLEAN™ position company for sustained revenue growth
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • October 2025FDA clearance of Tristel OPH and chlorine dioxide foam recognition in US standards
  • October 2025VISICLEAN™ product launch announced
  • +1 moreTrack every material event for Tristel plc as it happens. Explore monitoring →
Get alerted when Tristel plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Tristel plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Tristel plc operates in Healthcare - Infection Control/Hospital Disinfection Products. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare - Infection Control/Hospital Disinfection Products research →
NEW · MCP server

Ask your AI assistant about Tristel plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Tristel plc and its top competitor on Cyborg Score”
“What did Tristel plc do this quarter?”
“Is Tristel plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Tristel plc do?+
Tristel plc is a manufacturer of infection prevention products for hospitals, specializing in chlorine dioxide chemistry used for the decontamination of medical devices and sporicidal disinfection of environmental sur...
What is Tristel plc's Cyborg Score?+
Tristel plc has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Tristel plc's main competitors?+
Named competitors include Medical Device Sterilization/Disinfection, Environmental Surface Disinfection. The full competitive landscape is in the AskCyborg report.
How can I get the full Tristel plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Tristel plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Tristel plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual